Modelli di dati selezionati

Devi effettuare il log in per selezionare i modelli di dati da scaricare per successive analisi

20 Risultati di ricerca.
rilevanza Valutazione Più recente Meno recente

Southwest Oncology Group Registration Form (S0421) NCT00134056

- 20/09/21 - 1 modulo, 3 itemgroups, 40 elementi, 1 linguaggio
Itemgroups: Header, Patient demographics, Miscellaneous Patient Information
Southwest Oncology Group Registration Form (S0421) NCT00134056 Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F15A11DF-588A-2157-E034-0003BA3F9857

Southwest Oncology Group S0421 FACT-P Questionnaire: Step 1 Randomization Form NCT00134056

- 20/09/21 - 1 modulo, 3 itemgroups, 53 elementi, 1 linguaggio
Itemgroups: Header, Randomization questions, Patient status assessment
Southwest Oncology Group S0421 FACT-P Questionnaire: Step 1 Randomization Form NCT00134056 Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F159B9D6-FD84-2C7B-E034-0003BA3F9857

Radium-223 Dichloride (Alpharadin) DRKS00006460 NCT01618370 in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases - Radium 223 Dichloride (Alpharadin) - Screening Visit

- 13/02/17 - 1 modulo, 9 itemgroups, 89 elementi, 1 linguaggio
Itemgroups: Demography, Vital Signs, Prostate Cancer Classification, BPI-SF, ECOG Performance Status, Prior radiotherapy, Prior diagnostic and therapeutic procedures for prostate cancer, Hematology (with DBC), General chemistry - Serum
This study is a prospective, interventional, open-label, multi-center early access program for the use of Ra-223 Cl2 in HRPC/CRPC (Hormone refractory prostate cancer / Castrate resistant prostate cancer) patients diagnosed with bone metastasis and to collect additional short and long term safety data on the product. NCT01618370

SOUTHWEST ONCOLOGY GROUP S0421 TREATMENT FORM: Step 1 Randomization Form

- 28/07/15 - 1 modulo, 5 itemgroups, 26 elementi, 1 linguaggio
Itemgroups: Header, STATUS, TREATMENT, ARM 1 + ARM 2, COMMENTS
SOUTHWEST ONCOLOGY GROUP S0421 TREATMENT FORM: Step 1 Randomization Form Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F15A78DC-93A4-2746-E034-0003BA3F9857

Southwest Oncology Group Registration Form Step 2 (S0421) NCT00134056

- 27/06/15 - 1 modulo, 2 itemgroups, 18 elementi, 1 linguaggio
Itemgroups: SWOG clinical trial administrative data, Patient demographics
Southwest Oncology Group Registration Form Step 2 (S0421) NCT00134056 Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=0F977EF7-B9B7-51FB-E044-0003BA3F9857

CALGB: 90202 Baseline Solid Tumor Evaluation Form NCT00079001

- 21/06/15 - 1 modulo, 5 itemgroups, 23 elementi, 1 linguaggio
Itemgroups: Header, Patient demographics, Target Lesion(s) Baseline Evaluation, Non-target lesion(s) Baseline Evaluation, CCRR MODULE
CALGB: 90202 Baseline Solid Tumor Evaluation Form NCT00079001 Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B4605F45-F7E1-0518-E034-0003BA12F5E7

SOUTHWEST ONCOLOGY GROUP S0421 PAIN MEDICATION LOG AND PAIN ASSESSMENT: Step 2 Post-Chemo Form NCT00134056

- 12/06/15 - 1 modulo, 3 itemgroups, 17 elementi, 1 linguaggio
Itemgroups: Header, Patient Instructions, Patient medical history
SOUTHWEST ONCOLOGY GROUP S0421 PAIN MEDICATION LOG AND PAIN ASSESSMENT: Step 2 Post-Chemo Form NCT00134056 Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=0F9D64D5-FB3B-3049-E044-0003BA3F9857

Metastatic Cancer NCT00134056 Toxicity - SOUTHWEST ONCOLOGY GROUP S0421 ADVERSE EVENT FORM: Step 1 Randomization - 2305232v3.0 - SOUTHWEST ONCOLOGY GROUP S0421 ADVERSE EVENT FORM: Step 1 Randomization

- 09/01/15 - 1 modulo, 3 itemgroups, 20 elementi, 1 linguaggio
Itemgroups: Header, ADVERSE EVENTS, Comments
SOUTHWEST ONCOLOGY GROUP S0421 ADVERSE EVENT FORM: Step 1 Randomization Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F15B0C64-8BEB-3314-E034-0003BA3F9857

Metastatic Cancer NCT00134056 Toxicity - SOUTHWEST ONCOLOGY GROUP S0421 ADVERSE EVENT SUMMARY FORM: Step 2 Post-Chemo Form - 2464820v1.0 - SOUTHWEST ONCOLOGY GROUP S0421 ADVERSE EVENT SUMMARY FORM: Step 2 Post-Chemo Form

- 09/01/15 - 1 modulo, 3 itemgroups, 20 elementi, 1 linguaggio
Itemgroups: Header, ADVERSE EVENTS, Comments
SOUTHWEST ONCOLOGY GROUP S0421 ADVERSE EVENT SUMMARY FORM: Step 2 Post-Chemo Form Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=0F9D4F4F-BA23-2F60-E044-0003BA3F9857

Prostate Cancer NCT00079001 On-Study - CALGB 90202: Skeletal Survey Form - 2083769v3.0 - CALGB 90202: Skeletal Survey Form

- 09/01/15 - 1 modulo, 1 ItemGroup, 22 elementi, 1 linguaggio
ItemGroup: CCRR MODULE
CALGB 90202: Skeletal Survey Form Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B7BE7E12-C8DF-7003-E034-0003BA12F5E7

Metastatic Cancer NCT00134056 Response - Southwest Oncology Group - Bisphosphonate Usage Form - 2759910v1.0 - Southwest Oncology Group - Bisphosphonate Usage Form

- 09/01/15 - 1 modulo, 3 itemgroups, 19 elementi, 1 linguaggio
Itemgroups: Header, Header, Comments
Southwest Oncology Group - Bisphosphonate Usage Form Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=4FD609AB-09CA-1C94-E044-0003BA3F9857

Metastatic Cancer NCT00134056 Response - SOUTHWEST ONCOLOGY GROUP PROSTATIC SPECIFIC ANTIGEN REPORTING FORM - 2304629v3.0 - SOUTHWEST ONCOLOGY GROUP PROSTATIC SPECIFIC ANTIGEN REPORTING FORM

- 09/01/15 - 1 modulo, 3 itemgroups, 12 elementi, 1 linguaggio
Itemgroups: Header, PSA MEASUREMENTS, Comments
SOUTHWEST ONCOLOGY GROUP PROSTATIC SPECIFIC ANTIGEN REPORTING FORM Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F159832A-A1FF-27F6-E034-0003BA3F9857

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial